TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bringaker Biofrakt AS
Closing information (x1000 DKK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
9,430
|
6,862 | |
| Financial expenses |
3
|
0 | |
| Earnings before taxes |
960
|
1,410 | |
| Total assets |
5,121
|
4,998 | |
| Current assets |
2,117
|
1,644 | |
| Current liabilities |
1,540
|
2,030 | |
| Equity capital |
3,282
|
2,667 | |
| - share capital |
334
|
351 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
64.1%
|
53.4% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.2%
|
20.5% | |
| Return on assets (ROA) |
18.8%
|
28.2% | |
| Current ratio |
137.5%
|
81.0% | |
| Return on equity (ROE) |
29.3%
|
52.9% | |
| Change turnover |
2,913
|
857 | |
| Change turnover % |
12%
|
45%
|
14% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.